- Enhances fibrinolytic activity
- Improves glycemic control and lipoprotein metabolism
- Improves metabolic parameters & cardiovascular risk factors in new diagnosed Type-II diabetes patients
GLIMEPIRIDE
VOGLIBOSE
- An anti-diabetic agent that improves postprandial hyperglycemia.
- Delays the digestion & absorption of sugar, Lowering blood sugar levels.
- Less gastrointestinal side effects compared to Acarbose reported in some studies.
METFORMIN
- Effectively lowers glycosylated hemoglobin (HbA1c) & improves metabolic variables like dyslipidemia, fibrinolysis